Biomarkers study for bone metastasis in cancer
Part of Cancer clinical trials.
This study collects samples to find biomarkers related to bone metastases in common cancers. It might help doctors better understand why cancer spreads to bones.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have breast, lung, kidney, stomach/bowel, or prostate cancer that has spread to the bones
- You are willing to take part and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines special particles in your blood called exosomes to see if they can predict whether prostate cancer might spread to your bones. Researchers will collect a blood sample before any cancer treatment to look for RNA signatures that might indicate bone metastasis risk.
This study aims to create new laboratory models to better understand sarcomas and cancers that have spread to the bone or lungs. By using donated tumor tissue and blood, researchers hope to learn how these cancers grow and develop, which could lead to better treatments in the future.
This study is a national database that collects information from people with cancer that has spread to their bones from a solid tumor. By joining, you will help doctors learn more about bone metastases and improve care for future patients.
This study looks at people with cancer that has spread to the bones. It uses your medical imaging and records to understand your risk of bone fracture, without testing any new treatment.
This study is creating a registry to track information about people with bone metastases (cancer that has spread to the bones) who need treatment for symptoms. It may help researchers learn more about these conditions.
This study looks at “biomarkers,” which are measurable signs in the body (often in blood or samples), in people with lung or other chest cancers. It may help researchers better understand these cancers and improve how they’re diagnosed or tracked.
Hear when a new Bone Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.